Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DMAAU”, Tuesday, January 28, 2025.
The new SPAC intends to combined with a target company in the pharmaceutical industry that has products derived from plant-based raw materials.
Drugs Made in America’s sponsor team is led by Chief Executive Officer and Executive Chair Lynn Stockwell, and Chief Financial Officer Glenn Worman. Catherine Do, Sridhar Prasad and Myron W. Shulgan will serve on its Board of Directors.
Total SPAC deal count for 2025 year-to-date is now 6. This offering is expected to close on Wednesday, January 29, 2025.
Clear Street is acting as the sole book-running manager in the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Winston & Strawn LLP serving as Underwriter’s Counsel. MaloneBailey LLP serves as auditor. Wilmington Trust, National Association is acting as trustee.
One of the eternal questions surrounding SPACs has been their ability or inability to match the opportunity and the performance of the traditional IPO route, and it has become received wisdom on Wall Street that SPACs don’t match up. This is ostensibly born out in in the aggregate statistics that are frequently cited. But, downside...
At the SPAC of Dawn Despite the specter of recession looming, many of the hot technology sectors that SPACs favored during the boom times appear to be coming back on the menu. Ares II (NYSE:AACT) is reportedly angling to lock down a deal with an autonomous trucking firm. Northern Genesis II and Reinvent Y each...
Cantor Equity Partners II (NASDAQ:CEPT) filed another warrantless SPAC showing that the firm will not be slowing down despite Cantor CEO Howard Lutnick moving his attentions to the administration. The new $200 million SPAC would join Cantor Equity Partners I (NASDAQ:CEPO), which became the first SPAC to IPO this year and Cantor Equity Partners (NASDAQ:CEP),...
At the SPAC of Dawn US market futures continue to be flash dark red after a major down day saw SPAC-favorite exchange Nasdaq lose about -4% of its value leaving it running down -9.5% on the year. The sudden downturn has been somewhat personal for the administration as Trump Media (NASDAQ:DJT) itself fell about -11.5%...
Titan Acquisition Corp has filed for a $240 million SPAC IPO, aiming to focus on opportunities in the finance and tech-enabled services industry. The blank-check company intends to list on the Nasdaq under the symbol “TACHU”, offering 24,000,000 units at $10.00 each, with the trust funded at 100.5%. The unit structure includes one-half of one...